Here, using reprogrammed cells from patients affected with HGPS, progeria-like syndrome (HGPS-L) or APS, we have broadened the description of the phenotypic cellular alterations linked to causative LMNA mutations. The gene discussed is LMNA; the disease is autoimmune polyendocrinopathy.